Co-Founders Serge Saxonov and Ben Hindson give us a corporate overview and demonstrate the Chromium single cell platform.

Co-founder, Chairman & CEO Ken Drazan explains the array of applications that Arsenal engineers into its CAR-T cells.

CEO Fabian Gerlinghaus shares a business overview and VP of R&D Daniele Malleo gives a hands on tour of how the Cell Shuttle works.

Andrew Ward describes the foundational research Scripps has made regarding coronavirus and HIV research.

Travis Young explains the idea behind Calibr and describes a switchable CAR-T program that has been developed there.

Kristin Yarema, CEO starting Jan 1st, describes Poseida's approach to allo CAR-T and then CMC expert Chad Headlee gives us a tour.

CEO John Evans gives an update on Beam's pipeline and then we take a lab tour to see the science in action with President Pino Ciaramella.

Discussing rare disease, psychiatric research, infectious disease, and cancer with experts from the Broad Institute.

Jake Becraft describes emerging new techniques in using mRNA and gives BiotechTV a tour of Strand’s Fenway HQ to show us the R&D process.

Tessera’s CEO explains gene writing and then we take a tour to learn about high-throughput testing, RNA purification, and LNP encapsulation.

BiotechTV toured Bayer’s Kendall Square location to see how it collaborates with the local biotech ecosystem.

Nello Mainolfi explains the concept of protein degradation and describes three key technologies that enable precision protein measurement.

Paul Bolno shows us how Wave discovers and develops its own oligonucleotides as Wave prepares to enter the clinic with RNA editing.

Vizgen’s CEO and Co-founder show how spatial genomics allows scientists to visualize the expression of hundreds of genes in a tissue sample.

BiotechTV tours the Cambridge, Mass headquarters of Seres Therapeutics.

Aera Therapeutics takes BiotechTV along as it builds a highly automated lab at its new headquarters in Cambridge, Mass.

GRO Biosciences CEO Dan Mandell explains how new technologies enable small companies to test new ideas widely.

Dennis Huang, CTO of Ultragenyx, walks us through gene therapy manufacturing at the grand opening the company's new Bedford, MA plant.

Novocure Executive Chairman Bill Doyle explains the science behind tumor treating fields and illustrates the patient experience.

Cryoport's Mark Sawicki demonstrates how CAR-T and gene therapies are shipped in high tech shipping containers.